MedPiper Technologies vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Bengaluru Diagnostics-as-a-Service API connecting 10,000+ India labs for telehealth and insurers; YC W20 $3.28M at 91% YoY growth enabling digital health platforms to embed diagnostics without logistics.
About
MedPiper Technologies is a Bengaluru-based Diagnostics-as-a-Service (DaaS) platform — India's first comprehensive diagnostic infrastructure API — enabling insurers, health plans, telehealth providers, and healthcare organizations to embed diagnostic services (lab tests, radiology, home sample collection) into their digital health workflows through a single white-label integration. Founded in 2020 and backed by Y Combinator (W20) with $3.28 million raised, MedPiper generates ₹5.57 crore (approximately $670,000 USD) in annual revenue with 91% year-over-year growth, serving the digital health ecosystem as the infrastructure layer that connects healthcare platforms to India's fragmented diagnostic laboratory network.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.